相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Complex patterns of ETS gene alteration arise during cancer development in the human prostate
J. Clark et al.
ONCOGENE (2008)
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
G. Attard et al.
ONCOGENE (2008)
Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin M reduces hypertriglyceridemia through enhanced β-oxidation
Yue Zhou et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
New androgen receptor genomic targets show an interaction with the ETS1 transcription factor
Charles E. Massie et al.
EMBO REPORTS (2007)
Cell- and gene-specific regulation of primary target genes by the androgen receptor
Eric C. Bolton et al.
GENES & DEVELOPMENT (2007)
A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth
Qianben Wang et al.
MOLECULAR CELL (2007)
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Scott A. Tomlins et al.
NATURE (2007)
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
F. Demichelis et al.
ONCOGENE (2007)
Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis
K. Takayama et al.
ONCOGENE (2007)
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate
J. Clark et al.
ONCOGENE (2007)
Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells
Sangkil Nam et al.
MOLECULAR CANCER THERAPEUTICS (2007)
TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer
Karin G. Hermans et al.
CANCER RESEARCH (2006)
Long-term outcome among men with conservatively treated localised prostate cancer
J. Cuzick et al.
BRITISH JOURNAL OF CANCER (2006)
Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells
G. Wang et al.
ONCOGENE (2006)
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming
Kristiina Iljin et al.
CANCER RESEARCH (2006)
Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias
Maisa Yoshimoto et al.
CANCER GENETICS AND CYTOGENETICS (2006)
TMPRSS2:: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
Sven Perner et al.
CANCER RESEARCH (2006)
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer
Jianghua Wang et al.
CANCER RESEARCH (2006)
Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer
Maria Johansson Soller et al.
GENES CHROMOSOMES & CANCER (2006)
Evolution of the androgen receptor pathway during progression of prostate cancer
Peter J. M. Hendriksen et al.
CANCER RESEARCH (2006)
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer
SA Tomlins et al.
CANCER RESEARCH (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines
HJ Zhao et al.
PROSTATE (2005)
Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome
CS Foster et al.
ONCOGENE (2004)
Natural history of early, localized prostate cancer
JE Johansson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Cellular and molecular pathology of prostate cancer precursors
CS Foster et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2000)
分享论文
